These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35061885)

  • 1. Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.
    Pemmaraju N; Wilson NR; Garcia-Manero G; Sasaki K; Khoury JD; Jain N; Borthakur G; Ravandi F; Daver N; Kadia T; DiNardo C; Jabbour E; Pierce S; Qazilbash M; Konopleva M; Kantarjian H
    Blood Adv; 2022 May; 6(10):3027-3035. PubMed ID: 35061885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
    He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients.
    Gong C; Liu Y; Zhang M
    Ther Adv Hematol; 2024; 15():20406207241251602. PubMed ID: 38832237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
    Adimora IJ; Wilson NR; Pemmaraju N
    Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
    Mehra S; Taylor J
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advances in therapy of blastic plasmacytoid dendritic cell neoplasm.
    Kerr D; Sokol L
    Expert Opin Investig Drugs; 2018 Sep; 27(9):733-739. PubMed ID: 30118336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant.
    Yun S; Chan O; Kerr D; Vincelette ND; Idrees A; Mo Q; Sweet K; Lancet JE; Kharfan-Dabaja MA; Zhang L; Sokol L
    Blood Adv; 2020 Jul; 4(14):3435-3442. PubMed ID: 32722779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.
    Pemmaraju N; Kantarjian H
    Clin Adv Hematol Oncol; 2023 May; 21(5):257-264. PubMed ID: 37145496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Pemmaraju N; Sweet KL; Stein AS; Wang ES; Rizzieri DA; Vasu S; Rosenblat TL; Brooks CL; Habboubi N; Mughal TI; Kantarjian H; Konopleva M; Lane AA
    J Clin Oncol; 2022 Sep; 40(26):3032-3036. PubMed ID: 35820082
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea.
    Kim HS; Kim HJ; Kim SH; Choi JY; Ko YH; Kim WS; Jung CW; Kim SJ
    Korean J Intern Med; 2017 Sep; 32(5):890-899. PubMed ID: 28870016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.
    Amitay-Laish I; Sundram U; Hoppe RT; Hodak E; Medeiros BC; Kim YH
    JAAD Case Rep; 2017 Jul; 3(4):310-315. PubMed ID: 28752118
    [No Abstract]   [Full Text] [Related]  

  • 15. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Kerr D; Zhang L; Sokol L
    Curr Treat Options Oncol; 2019 Feb; 20(1):9. PubMed ID: 30715612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
    Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
    Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
    Pemmaraju N; Kantarjian H; Sweet K; Wang E; Senapati J; Wilson NR; Konopleva M; Frankel AE; Gupta V; Mesa R; Ulrickson M; Gorak E; Bhatia S; Budak-Alpdogan T; Mason J; Garcia-Romero MT; Lopez-Santiago N; Cesarman-Maus G; Vachhani P; Lee S; Bhatt VR; Blum W; Walter RB; Bixby D; Gojo I; Duvic M; Rampal RK; de Lima M; Foran J; Fathi AT; Hall AC; Jacoby MA; Lancet J; Mannis G; Stein AS; Mims A; Rizzieri D; Olin R; Perl A; Schiller G; Shami P; Stone RM; Strickland S; Wieduwilt MJ; Daver N; Ravandi F; Vasu S; Guzman M; Roboz GJ; Khoury J; Qazilbash M; Aung PP; Cuglievan B; Madanat Y; Kharfan-Dabaja MA; Pawlowska A; Taylor J; Tallman M; Dhakal P; Lane AA
    Blood; 2023 Feb; 141(6):567-578. PubMed ID: 36399715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
    Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K
    Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of blastic plasmacytoid dendritic neoplasm in Chile: report of 10 cases].
    Micolich V; Peña C; Figueroa F; Briones V; Vidal C; Chandia M
    Rev Med Chil; 2023 Sep; 151(9):1201-1206. PubMed ID: 39093157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.